Ad hoc announcement pursuant to Art. 53 LR (IN BRIEF) Basilea Pharmaceutica has been awarded USD 6 million by the Biomedical Advanced Research and Development Authority to continue development of its investigational oral antibiotic ceftibuten-ledaborbactam etzadroxil for treating complicated urinary … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Security & Safety, Switzerland
Tagged antibiotic development, antimicrobial resistance, ASPR, BARDA, Basilea Advances Antibiotic Pipeline with BARDA Funding for Oral Beta Lactam Combination Therapy, Basilea Pharmaceutica, Basilea Receives USD 6 Million BARDA Funding to Advance Development of Oral Antibiotic for Drug Resistant Urinary Infections, beta lactam beta lactamase inhibitor, ceftibuten ledaborbactam etzadroxil, complicated urinary tract infections cUTI, Cresemba®, David Veitch, FDA Fast Track designation, multidrug resistant bacteria, pyelonephritis, Qualified Infectious Disease Product QIDP, US Department of Health and Human Services, Zevtera®
(IN BRIEF) Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, Basilea brings deep expertise in antibacterial and antifungal drug development, while expanding INCATE’s scope … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Non Profit, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged anti-infectives, antibacterial therapies, antifungal therapies, antimicrobial resistance, Basel life sciences, Basilea Joins INCATE to Advance Early-Stage Antibacterial and Antifungal Innovation in Europe, Basilea Pharmaceutica, biopharmaceutical innovation, clinical development, drug development, INCATE, industry partnership, infectious diseases, invasive fungal infections, Laurenz Kellenberger, preclinical research, Primo Schär, University of Basel
(IN BRIEF) ShanX Medtech, a spin-off from Eindhoven University of Technology, has raised €24 million in combined public and private funding to accelerate the development of its ultra-rapid antimicrobial susceptibility testing platform. The financing includes an oversubscribed €15 million seed … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged AMR, antimicrobial resistance, antimicrobial susceptibility testing, Ardjan van der Linden, AST, Borski Fund, Brabant Development Agency, Eindhoven University of Technology, European Commission funding, HADEA, Hera, High Tech Campus Eindhoven, In Vitro Diagnostics, Invest-NL, Jaap den Toonder, MedTech innovation, New €24 Million Investment Positions ShanX Medtech for Clinical Launch of Rapid AST Technology, ShanX Medtech, Sophia E Shanko, TU/e spin-off
(IN BRIEF) Fresenius Kabi’s Santiago de Besteiros plant in Portugal has secured BSI Kitemark™ Certification for Minimized Risk of AMR in its Ceftriaxone production, confirming compliance with the AMR Industry Alliance’s Antibiotic Manufacturing Standard. Key measures include stringent controls to … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Portugal, Science, Technology
Tagged AMR, AMR Industry Alliance, antibiotic efficacy, Antibiotic Manufacturing Standard, antimicrobial resistance, BSI Kitemark Certification, Ceftriaxone, Cristina Fernandes, EHS Management, emissions control, environmental protection, Fresenius Kabi, partnership, PORTUGAL, responsible pharmaceutical production, Santiago de Besteiros, sustainability, wastewater management, Zyad Hatquai
(IN BRIEF) In 2023, a historic initiative saw all 27 EU countries, along with Iceland and Norway, collecting and reporting both sales and usage data on veterinary antimicrobials for the first time. The resulting ESUAvet report details that 98% of … Read the full press release
Posted in Business, European Union, Financial, Government, Healthcare, Iceland, Industrial, Investment, Management, Netherlands, News, Norway, Science, Technology
Tagged 2023, AMEG, Animal Health, antimicrobial resistance, antimicrobials, ASU Platform, breeders, Category B, Category C, Category D, Cattle, chickens, EMA, ESUAvet, ESVAC, EU27, European Union, farmers, feed mills, food-producing animals, Iceland, Norway, penicillins, pharmacies, pigs, public health, retailers, sales data, sulfonamides, tetracyclines, turkeys, usage data, veterinarians, veterinary medicine
(IN BRIEF) Dr. Melissa Webby of the University of Warwick has received a £2.2 million Wellcome Career Development Award to research the mechanisms that protect Gram-negative bacteria from antibiotics. This award supports Dr. Webby’s mission to advance the understanding of … Read the full press release
Posted in Awards, Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged antibiotic resistance, antimicrobial resistance, Awards, bacterial envelope, biomedical research, Colin Kleanthous, Dr. Melissa Webby, Gram-negative bacteria, healthcare infections, leadership, microbiology, public health, research fellowship, University of Warwick, Wellcome Career Development Award
(IN BRIEF) Fresenius Kabi is addressing the global threat of antimicrobial resistance (AMR), which causes millions of deaths annually, through sustainable manufacturing, improved antibiotic access, and promoting responsible use. During AMR Awareness Week, the company highlighted its commitment to reducing … Read the full press release
(IN BRIEF) In his doctoral research at the University of Helsinki, Matej Zore demonstrated the potential of repurposing the drugs fingolimod and etrasimod, originally developed for autoimmune diseases, to combat antimicrobial resistance (AMR). These drugs showed notable efficacy against drug-resistant … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged antimicrobial resistance, etrasimod, fingolimod, Matej Zore, methicillin-resistant Staphylococcus aureus (MRSA), Professor Fredrik Almqvist, Professor Jari Yli-Kauhaluoma, Repurposing Drugs, University of Helsinki, vancomycin-resistant Enterococcus (VRE)
(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, United Kingdom
Tagged antimicrobial resistance, Dr Derek Cocker, Dr Kat Stott, Dr Steve Aston, Fleming Fund Programme, Nigeria, partnership, Professor Alison Holmes, Sierra Leone, sustainability, University of Liverpool
(IN BRIEF) The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR). They have been working together since 2018 to advance … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimicrobial Chemotherapy Conference, antimicrobial resistance, Dame Sally Davies, drug resistance, drug-resistant infections, GARDP, Global Antibiotic Research and Development Partnership, newborns, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
(IN BRIEF) Sandoz, a global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to acquire worldwide product rights for leading systemic antifungal agent Mycamine® (micafungin sodium, Funguard® in Japan) from Astellas. This acquisition will reinforce Sandoz’s hospital … Read the full press release
Workshop with regulators from EU, Japan and US open for registration LONDON, 28-May-2018 — /EuropaWire/ — The European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and the United States’ Food and Drug Administration (FDA) are co-organising a workshop to discuss the development … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged antibiotics for children, antimicrobial resistance, EMA, FDA, PMDA, workshop
Dundee, Scotland, 27-Mar-2017 — /EuropaWire/ — Antimicrobial resistance is one of the greatest threats to global human and animal health – the O’Neill Report published last year stated that, unless we take urgent action, it will be directly responsible for over … Read the full press release
LEICESTER, 06-Jan-2017 — /EuropaWire/ — A researcher from the University of Leicester has been awarded a prestigious Research Councils grant to study antimicrobial resistance (AMR) from a new perspective. Dr Carolyn Tarrant, Associate Professor and co-lead of the SAPPHIRE research group … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?